Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Baxter Healthcare is recalling 542,080 bags of 0.9% Sodium Chloride Injection USP due to confirmed reports of blue plastic fragments from vial adapters.
Navinta LLC is recalling Fomepizole Injection due to FDA inspection findings of GMP violations that may impact sterility. The recall covers 14,628 units distributed nationwide.
Hospira Inc. is voluntarily recalling specific lots of Ketorolac Tromethamine Injection due to crystallization. The recall covers vials distributed nationwide and internationally.
Hospira Inc. is voluntarily recalling specific lots of Ketorolac Tromethamine Injection because of crystallization. The affected vials were distributed nationwide and in Guam and Singapore.
Baxter Healthcare is recalling 7,444 containers of Clinimix E 5/20 due to a lack of assurance of sterility and increased leak complaints.
Baxter Healthcare is recalling 196,128 containers of 0.9% Sodium Chloride Injection due to lack of sterility assurance and leak complaints.
Baxter Healthcare is recalling 0.9% Sodium Chloride Injection due to reports of missing closures and leaks that may compromise sterility.
Baxter Healthcare is recalling 48,874 units of 5% Dextrose Injection because missing closures or leaks may compromise sterility.
Bethel Nutritional Consulting is recalling B-Lipo capsules because they contain Lorcaserin, a controlled substance, and were marketed without FDA approval.
Mylan Institutional LLC is recalling Haloperidol Decanoate Injection because leaking vials raised concerns about the product's sterility.
Mylan Institutional LLC is recalling specific lots of Haloperidol Decanoate Injection due to leaking vials that compromise sterility assurance.
Heritage Pharmaceuticals is recalling RIFAMPIN for Injection, USP, 600 mg per vial, due to quality control concerns regarding the assurance of sterility.
Heritage Pharmaceuticals is recalling Colistimethate Sodium Injection due to quality control concerns regarding sterility assurance.
Mutual Pharmaceutical is recalling Ergoloid Mesylates 1 mg tablets because they failed impurity and degradation specifications during stability testing.
Hospira is recalling 94,440 bags of 5% Dextrose Injection due to a potential leak at the administrative port that compromises sterility.
Fusion Pharmaceuticals is recalling 9,439 kits of Dicopanil oral suspension due to microbial contamination with Burkholderia multivorans. The affected kits were distributed in California.
Actavis Inc. is voluntarily recalling 29,405 cartons of Vancomycin Hydrochloride Capsules, USP, 250 mg, because the drug was found to be subpotent.
Sagent Pharmaceuticals is recalling Atracurium Besylate Injection vials because FDA observations suggest potential impacts on product sterility.
Sagent Pharmaceuticals is recalling Atracurium Besylate Injection vials because FDA observations regarding aseptic and GMP practices at the manufacturing site may have impacted product sterility.
Actavis Inc. is voluntarily recalling 51,472 cartons of Vancomycin Hydrochloride Capsules, USP, 125 mg, because the drug is subpotent.
Par Pharmaceutical Inc. is recalling Mafenide Acetate 5% Topical Solution packets due to the presence of oxidized steel, organic material, and shredded polypropylene.
Hospira Inc. is recalling 142,644 bags of Lactated Ringer's and 5% Dextrose Injection USP due to confirmed mold particulates in the solution.
Hospira Inc. is recalling 2,500 vials of Propofol Injectable Emulsion because the products experienced uncontrolled temperature excursions during transit.
Hospira is recalling specific vials of 1% Lidocaine Hydrochloride Injection because a returned sample contained human hair attached to the stopper.
AnazaoHealth Corporation is recalling 51 vials of Compounded Plaquex intravenous injection nationwide because the product contains an active pharmaceutical ingredient from an unapproved source.